Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: June 2014

Ethosuximide

Suggested reading

Callaghan N, O’Hare J, O’Driscoll D, O’Neill B, Dally M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Developmental Medicine and Child Neurology 1982; 24: 830–836.
Capovilla G, Beccaria F, Veggiotti P, Rubboli G, Meletti S, Tassinari CA. Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy. Journal of Child Neurology 1999; 14: 395–400.
Giaccone M, Bartoli A, Gatti G, Marchiselli R, Pisani F, Latella MA, Perucca E. Effect of enzyme-inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. British Journal of Clinical Pharmacology 1996; 41: 575–579.
Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC. For the Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. New England Journal of Medicine 2010; 362: 790–799.
Mattson RH, Cramer JA. Valproic acid and ethosuximide interaction. Annals of Neurology 1980; 7: 583–584.
Panayiotopoulos CP. Treatment of typical absence seizures and related epileptic syndromes. Paediatric Drugs 2001; 3: 379–403.
Patsalos PN. Antiepileptic drug interactions – A clinical guide. 2nd Edition. 2013, Springer, London, UK; 2013.
Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database of Systematic Reviews 2005; 4: CD003032.
Rowan AJ, Meiser JW, De-Beer-Pawlikowski N. Valproate-ethosuximide combination therapy for refractory absence seizures. Archives of Neurology 1983; 40: 797–802.
Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, Kupferberg HJ. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982; 32: 157–163.
Snead OC, Horsey L. Treatment of epileptic falling spells with ethosuximide. Brain Development 1987; 9: 602–604.